Migraine Clinical Trials in Philadelphia

Showing 21-40 of 120 trials

Migraine and CVD Risk in Women

NCT03081390

The primary goal of this study is to test the effects of a high-fat, high-carbohydrate mixed meal on candidate modulators of cardiovascular disease risk (inflammation, vascular reactivity, sympathetic nervous system tone, and response to pain) in young adult women with migraine compared with healthy young women. This is study enrolling both cases (women with migraine) and controls (women without migraine), with equal numbers of normal weight and obese women in each group. Participants will undergo a telephone screening and a single day in-person study visit.

Migraine

University of Pennsylvania30 participantsStarted Apr 2017

Philadelphia, Pennsylvania, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 4< 1 mile

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

NCT05207865

The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.

MigraineEpisodic MigrainePhonophobia+1 more

Pfizer441 participantsStarted Mar 2022

Phoenix, Arizona, United States • Hawthorne, California, United States • North Hollywood, California, United States +16 more locations

Migraine and CVD Risk in Women

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Migraine Trials in Other Cities

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)

A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

PArtial REbreathing for Migraine With Aura 1

Do Patients With Chronic Daily Headache Have Continuous Headache or Moments of Headache Relief?

Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1

Real-world Data Analysis of REN Treatment in Adolescence With Migraine

Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN)

Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN)

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

A Phase III Trial of e-TNS for the Acute Treatment of Migraine

A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

Observational Study to Assess Migraine Prediction Tool

A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine

BE WELL With Migraine: Brain Education and WELLness With Migraine

CorPath® GRX Neuro Study

Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine

Other Conditions in Philadelphia